文献速递垂体与肾上腺疾病

分泌促肾上腺皮质激素的胰腺神经内分泌肿瘤的临床特征与分子机制

The Clinical Features and Molecular Mechanisms of ACTH-secreting Pancreatic Neuroendocrine Tumors.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

该研究纳入2001至2019年瑞金医院诊断的7例分泌促肾上腺皮质激素(ACTH)的胰腺神经内分泌肿瘤(pNET)患者,以20例分泌ACTH的胸腺神经内分泌肿瘤(TNET)和7例无功能pNET为对照,检测POMC启动子CpG甲基化。结果显示ACTH分泌性pNET临床生化特征与TNET相似但预后显著更差,POMC启动子低甲基化导致pNET产生ACTH。

要点

  • 7例ACTH分泌性pNET均有ACTH和尿游离皮质醇升高,胰腺ACTH染色阳性。
  • 与ACTH分泌性TNET相比,ACTH分泌性pNET临床生化特征相似但预后显著更差。
  • ACTH分泌性pNET的POMC启动子CpG甲基化显著低于无功能pNET和正常胰腺。

核心结论

  • ACTH分泌性pNET具有侵袭性且致命。
  • 对于可切除原发肿瘤且无转移的患者,手术是确定性治愈手段。
  • POMC启动子低甲基化导致pNET产生ACTH。

研究设计与样本

  • 纳入2001至2019年在上海临床内分泌代谢病中心和瑞金医院胰腺疾病中心诊断的7例分泌ACTH的pNET患者。
  • 另纳入20例分泌ACTH的TNET患者和7例无功能pNET患者作为对照。
  • 收集临床数据并检测POMC启动子CpG甲基化。

主要发现

  • 7例患者均有ACTH和尿游离皮质醇水平升高,胰腺ACTH染色阳性,诊断为分泌ACTH的pNET。
  • 7例中6例接受手术,1例接受经动脉栓塞(TAE)。
  • 2例术后无病生存;2例术后90天内死亡;3例出现转移并在1年内死亡。
  • 与分泌ACTH的TNET相比,分泌ACTH的pNET临床和生化特征相似但预后显著更差。
  • 分泌ACTH的pNET中POMC启动子CpG甲基化显著低于无功能pNET和正常胰腺。

临床怎么用

  • 对于可切除原发肿瘤且无转移的患者,手术是确定性治愈手段(作者结论)。
  • 原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pancreatic neuroendocrine tumors (pNETs) causing ectopic adrenal corticotropic hormone (ACTH) syndrome (EAS) are rare and aggressive with little known information. We aimed to elucidate the clinical features and molecular mechanisms of pNETs with EAS by methylation analysis. METHODS: Seven patients with ectopic ACTH-secreting pNETs who were diagnosed at Shanghai Clinical Endocrine and Metabolic Diseases Center and Pancreatic Disease Center in Ruijin Hospital between 2001 and 2019 were enrolled. Twenty patients with ectopic ACTH-secreting thymic neuroendocrine tumors (TNETs) and 7 with nonfunctional pNETs (nf-pNETs) were also enrolled as controls. We collected clinical data and measured POMC promoter CpG methylation. RESULTS: All 7 patients had elevated ACTH and urinary free cortisol (UFC) levels with positive ACTH staining in the pancreas and were diagnosed with ectopic ACTH-secreting pNET. Of the 7 patients, 6 underwent surgery and 1 underwent transarterial embolization (TAE). Two patients were free of disease after surgery; 2 died within 90 days after surgery; and 3 had metastases and died within 1 year. Compared with ACTH-secreting TNETs, ACTH-secreting pNETs had similar clinical and biochemical features but a significantly poorer prognosis. POMC promoter CpG methylation was significantly lower in ACTH-secreting pNETs than in nf-pNETs and normal pancreas. CONCLUSIONS: ACTH-secreting pNETs are aggressive and fatal. Surgery is definitively curative for patients with resectable primary tumors without metastasis. Pro-opiomelanocortin (POMC) promoter hypomethylation caused pNETs to produce ACTH. This study further supplements the genetic features of ACTH-secreting NETs.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Zhang C, Jin J, Xie J, et al. The Clinical Features and Molecular Mechanisms of ACTH-secreting Pancreatic Neuroendocrine Tumors. J Clin Endocrinol Metab. 2020. PMID: 32785672. doi:10.1210/clinem/dgaa507

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。